NeuroNews Issue 38

461

Highlights:

  • COVID-19 causes “widespread disruption” to neuroendovascular research around the globe
  • Stroke risk found higher in patients with COVID-19 than influenza
  • Thrombectomy proved efficacious in Latin America as the final results of RESILIENT are published
  • Profile: Richard P Klucznik (Houston, USA)
  • Neuromodulation: Non-invasive vagus nerve stimulation (VNS) may provide clinical benefit to patients with COVID-19


LEAVE A REPLY

Please enter your comment!
Please enter your name here